# Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis

> **NCT00690118** · PHASE2 · TERMINATED · sponsor: **University of Ulm** · enrollment: 219 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** pioglitazone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00690118
- **Lead sponsor:** University of Ulm
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-05
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 219 (ACTUAL)
- **Why stopped:** The interim analysis showed no tendency in favour of the verum group. Therefore it was decided to stop the study prematurely.
- **Last updated:** 2015-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00690118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00690118, "Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00690118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*